Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Chem Biol Drug Des. 2011 Apr 26;77(6):431–440. doi: 10.1111/j.1747-0285.2011.01111.x

Table 1.

Amino acid sequences and mass spectral analysis for compstatin peptides used in SPR experiments.

Peptide
#
Peptide Name Amino Acid Sequencea Mass
Spectral
Analysisb
I Linear I AVVQDWGHHRA T-(PEG)8-K-(biotin)-NH2 2267.06
II Parent I[CVVQDWGHHRC]T-(PEG)8-K-(biotin)-NH2 2327.6
III W4/A9 I[CVWQDWGAHRC]T-(PEG)8-K-(biotin)-NH2 2349.2
IV SQ027 W[CVWQDWGTNRC]W-(PEG)8-K-(biotin)-NH2 2514.9
V SQ059 D[CVWQDWGTNKC]W-(PEG)8-K-(biotin)-NH2 2414.93
VI SQ086 Q[CVWQDWGQNQC]W-(PEG)8-K-(biotin)-NH2 2454.4
VII W4/A9/W13 Ac-I[CVWQDWGAHRC]W-(PEG)8-K-(biotin)-NH2 2476.0
VIII W1/W4/A9 Ac-W[CVWQDWGAHRC]T-(PEG)8-K-(biotin)-NH2 2464.0
IX W1/W4/A9/W13 Ac-W[CVWQDWGAHRC]W-(PEG)8-K-(biotin)-NH2 2548.7
X W(i, i+3)/A9 Ac-W[CVWQDWGAWRC]W-(PEG)8-K-(biotin)-NH2 2598.5
a

Brackets denote cyclization. Sequence differences of various compstatin peptides from parent compstatin are shown in bold characters.

b

Molecular masses were provided by Abgent Inc.